Monster Beverage Corp vs Nomura Holdings Inc — how do they compare? Monster Beverage Corp trades at $43.64 (market cap $85.51B), while Nomura Holdings Inc trades at $9.59 (market cap $27.55B). The key difference: Monster Beverage Corp is far larger — about 3.1× Nomura Holdings Inc's market cap, and Nomura Holdings Inc pays a 3.4% dividend while Monster Beverage Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Monster Beverage Corp for 72 Days and Nomura Holdings Inc for 55 Days on average.
| MNST | NMR | |
|---|---|---|
Market Cap | $85.51B | $27.55B |
Volume | 8,569,709 | 782,470 |
Sector | Consumer Staples | Financials |
52-Week High | $49.97 | $10.86 |
52-Week Low | $33.16 | $6.73 |
Typical Hold Time | 72 Days | 55 Days |
Enterprise Value | $83.81B | $38.54T |
Dividend Yield | — | 3.4% |
Signals from Pluang's Aura AI — not financial advice
Monster Beverage (MNST) trades at $43.65, up 1.8% with bullish technical signals and strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $0.30 exceeding expectations. Revenue growth accelerated to $8.29B in 2025 with impressive 23.08% net margins. Analyst consensus is bullish with 52% buy ratings and $98.22 price target, representing 125% upside potential. Recent 1:2 stock split on August 11, 2026, enhances accessibility while maintaining zero long-term debt.
MNST presents compelling growth prospects with international expansion driving 35% sales surge and clean balance sheet. However, elevated valuation multiples (P/E 40.42) and regulatory challenges in key markets like India pose risks. The stock's technical strength and fundamental momentum support continued upside, though investors should monitor margin pressures from inflation and competitive dynamics in the energy drink sector.
Nomura Holdings (NMR) trades at $9.54, up 0.1% on the day, with a bearish technical signal but strong fundamental metrics including a P/E of 11.33 and net income margin of 20.4%. Recent earnings show a mix of beats and misses, while cash flow trends indicate significant financing activity. The stock is near its support level of $9, with RSI indicators suggesting potential oversold conditions. Zacks Research highlighted NMR as a strong buy for momentum and value in September 2026, citing recent price strength.
The outlook for NMR is cautiously optimistic, supported by solid profitability and valuation, but tempered by bearish technicals and inconsistent earnings performance. Key risks include high debt levels and macroeconomic sensitivity, while analyst sentiment leans hold. Upside potential exists if earnings stabilize and technical support holds.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →